GSK Pharma Submits FY26 BRSR Report

GlaxoSmithKline Pharmaceuticals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. This report, which is part of the Annual Report, aligns with the 9 principles of the National Guidelines on Responsible Business Conduct (NGRBC) set by the Ministry of Corporate Affairs. It covers environmental, social, and governance (ESG) parameters, detailing disclosures on general aspects, management processes, and principle-wise performance. The report aims to enhance the connection between financial reporting and the management of sustainability impacts within the company's operations.